236 related articles for article (PubMed ID: 22673622)
1. The UDP-sugar-sensing P2Y(14) receptor promotes Rho-mediated signaling and chemotaxis in human neutrophils.
Sesma JI; Kreda SM; Steinckwich-Besancon N; Dang H; García-Mata R; Harden TK; Lazarowski ER
Am J Physiol Cell Physiol; 2012 Sep; 303(5):C490-8. PubMed ID: 22673622
[TBL] [Abstract][Full Text] [Related]
2. Purinergic signaling and immune cell chemotaxis. Focus on "the UDP-sugar-sensing P2Y14 receptor promotes Rho-mediated signaling and chemotaxis in human neutrophils".
O'Grady SM
Am J Physiol Cell Physiol; 2012 Sep; 303(5):C486-7. PubMed ID: 22673620
[No Abstract] [Full Text] [Related]
3. Functional expression of the P2Y14 receptor in human neutrophils.
Scrivens M; Dickenson JM
Eur J Pharmacol; 2006 Aug; 543(1-3):166-73. PubMed ID: 16820147
[TBL] [Abstract][Full Text] [Related]
4. A selective high-affinity antagonist of the P2Y14 receptor inhibits UDP-glucose-stimulated chemotaxis of human neutrophils.
Barrett MO; Sesma JI; Ball CB; Jayasekara PS; Jacobson KA; Lazarowski ER; Harden TK
Mol Pharmacol; 2013 Jul; 84(1):41-9. PubMed ID: 23592514
[TBL] [Abstract][Full Text] [Related]
5. Gi-dependent cell signaling responses of the human P2Y14 receptor in model cell systems.
Fricks IP; Carter RL; Lazarowski ER; Harden TK
J Pharmacol Exp Ther; 2009 Jul; 330(1):162-8. PubMed ID: 19339661
[TBL] [Abstract][Full Text] [Related]
6. Thrombin-promoted release of UDP-glucose from human astrocytoma cells.
Kreda SM; Seminario-Vidal L; Heusden Cv; Lazarowski ER
Br J Pharmacol; 2008 Apr; 153(7):1528-37. PubMed ID: 18204471
[TBL] [Abstract][Full Text] [Related]
7. P2Y(1), P2Y(2), P2Y(4), and P2Y(6) receptors are coupled to Rho and Rho kinase activation in vascular myocytes.
Sauzeau V; Le Jeune H; Cario-Toumaniantz C; Vaillant N; Gadeau AP; Desgranges C; Scalbert E; Chardin P; Pacaud P; Loirand G
Am J Physiol Heart Circ Physiol; 2000 Jun; 278(6):H1751-61. PubMed ID: 10843869
[TBL] [Abstract][Full Text] [Related]
8. UDP-glucose acting at P2Y14 receptors is a mediator of mast cell degranulation.
Gao ZG; Ding Y; Jacobson KA
Biochem Pharmacol; 2010 Mar; 79(6):873-9. PubMed ID: 19896471
[TBL] [Abstract][Full Text] [Related]
9. Functional expression of the P2Y14 receptor in murine T-lymphocytes.
Scrivens M; Dickenson JM
Br J Pharmacol; 2005 Oct; 146(3):435-44. PubMed ID: 15997228
[TBL] [Abstract][Full Text] [Related]
10. UDP-sugars activate P2Y
Abbas ZSB; Latif ML; Dovlatova N; Fox SC; Heptinstall S; Dunn WR; Ralevic V
Vascul Pharmacol; 2018 Apr; 103-105():36-46. PubMed ID: 29253618
[TBL] [Abstract][Full Text] [Related]
11. The P2Y2 nucleotide receptor interacts with alphav integrins to activate Go and induce cell migration.
Bagchi S; Liao Z; Gonzalez FA; Chorna NE; Seye CI; Weisman GA; Erb L
J Biol Chem; 2005 Nov; 280(47):39050-7. PubMed ID: 16186116
[TBL] [Abstract][Full Text] [Related]
12. Characterization of the UDP-glucose receptor (re-named here the P2Y14 receptor) adds diversity to the P2Y receptor family.
Abbracchio MP; Boeynaems JM; Barnard EA; Boyer JL; Kennedy C; Miras-Portugal MT; King BF; Gachet C; Jacobson KA; Weisman GA; Burnstock G
Trends Pharmacol Sci; 2003 Feb; 24(2):52-5. PubMed ID: 12559763
[TBL] [Abstract][Full Text] [Related]
13. UDP-glucose sensing P2Y
Zhang JZ; Shi NR; Wu JS; Wang X; Illes P; Tang Y
Neuropharmacology; 2023 Nov; 238():109655. PubMed ID: 37423482
[TBL] [Abstract][Full Text] [Related]
14. Effects of purine and pyrimidine nucleotides on intracellular Ca2+ in human eosinophils: activation of purinergic P2Y receptors.
Mohanty JG; Raible DG; McDermott LJ; Pelleg A; Schulman ES
J Allergy Clin Immunol; 2001 May; 107(5):849-55. PubMed ID: 11344352
[TBL] [Abstract][Full Text] [Related]
15. Novel vasocontractile role of the P2Y₁₄ receptor: characterization of its signalling in porcine isolated pancreatic arteries.
Alsaqati M; Latif ML; Chan SL; Ralevic V
Br J Pharmacol; 2014 Feb; 171(3):701-13. PubMed ID: 24138077
[TBL] [Abstract][Full Text] [Related]
16. The P2Y14 receptor of airway epithelial cells: coupling to intracellular Ca2+ and IL-8 secretion.
Müller T; Bayer H; Myrtek D; Ferrari D; Sorichter S; Ziegenhagen MW; Zissel G; Virchow JC; Luttmann W; Norgauer J; Di Virgilio F; Idzko M
Am J Respir Cell Mol Biol; 2005 Dec; 33(6):601-9. PubMed ID: 16109883
[TBL] [Abstract][Full Text] [Related]
17. UDP-glucose modulates gastric function through P2Y14 receptor-dependent and -independent mechanisms.
Bassil AK; Bourdu S; Townson KA; Wheeldon A; Jarvie EM; Zebda N; Abuin A; Grau E; Livi GP; Punter L; Latcham J; Grimes AM; Hurp DP; Downham KM; Sanger GJ; Winchester WJ; Morrison AD; Moore GB
Am J Physiol Gastrointest Liver Physiol; 2009 Apr; 296(4):G923-30. PubMed ID: 19164486
[TBL] [Abstract][Full Text] [Related]
18. P2X1 ion channels promote neutrophil chemotaxis through Rho kinase activation.
Lecut C; Frederix K; Johnson DM; Deroanne C; Thiry M; Faccinetto C; Marée R; Evans RJ; Volders PG; Bours V; Oury C
J Immunol; 2009 Aug; 183(4):2801-9. PubMed ID: 19635923
[TBL] [Abstract][Full Text] [Related]
19. P2Y(6) agonist uridine 5'-diphosphate promotes host defense against bacterial infection via monocyte chemoattractant protein-1-mediated monocytes/macrophages recruitment.
Zhang Z; Wang Z; Ren H; Yue M; Huang K; Gu H; Liu M; Du B; Qian M
J Immunol; 2011 May; 186(9):5376-87. PubMed ID: 21444765
[TBL] [Abstract][Full Text] [Related]
20. Release of cellular UDP-glucose as a potential extracellular signaling molecule.
Lazarowski ER; Shea DA; Boucher RC; Harden TK
Mol Pharmacol; 2003 May; 63(5):1190-7. PubMed ID: 12695547
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]